The spectrophotometric determination of cisplatin in urine, using o-phenylenediamine as derivatizing agent

被引:39
作者
Anilanmert, B [1 ]
Yalçin, G [1 ]
Ariöz, F [1 ]
Dölen, E [1 ]
机构
[1] Marmara Univ, Fac Pharm, Dept Analyt Chem, TR-81010 Istanbul, Turkey
关键词
visible spectrophotometer; cis-diammindichloroplatinum (II); cisplatin (CDDP); o-phenylenediamine (OPDA); determination;
D O I
10.1081/AL-100002709
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A visible spectrophotometric method has been developed fur determination of the antitumour agent cis-diammindichloroplatinum (II) in urine. The method is based on the measurement of the absorbance of the reaction product of the drug and o-phenylenediamine. Optimum conditions of the reaction were established. The product was obtained at pH 6.2; in 30 min at 90 degreesC, giving a maximum absorbance at 705 nm, which is far beyond the wavelengths of the absorption of cisplatin itself, o-phenylenediamine, and the biomolecules in urine. The chloride ion interference and the other possible interferences originated from the urine matrix were overcome by using the standard addition method and also the high concentration of the reactant. The drug could be detected and determined without any interference. The reaction product was stable in urine for 5 days at ambient temperature. The standard addition curve was linear in the concentration range of 0.42-3.16 mug/ml in respect to the final concentration of cisplatin. The detection limit of cisplatin in spiked urine samples was 8.40 mug/ml.
引用
收藏
页码:113 / 123
页数:11
相关论文
共 18 条
[1]   Determination of cisplatin, transplatin and amminetri-chloroplatinate by high performance liquid chromatography in one run using 4-methyl-2-thiouracil as derivatizing agent [J].
Ariöz, F ;
Yalçin, G ;
Dölen, E .
CHROMATOGRAPHIA, 1999, 49 (9-10) :562-566
[2]  
BANISTER SJ, 1979, J CHROMATOGR, V173, P333
[3]  
BERTOLERO F, 1982, RES COMMUN CHEM PATH, V36, P273
[4]   SPECTROPHOTOMETRIC DETERMINATION OF PLATINUM WITH ORTHO-PHENYLENEDIAMINE [J].
GOLLA, ED ;
AYRES, GH .
TALANTA, 1973, 20 (02) :199-210
[5]  
HINCAL AA, 1979, J PAR DRUG ASS, V33, P108
[6]  
INAGAKI K, 1985, CHEM PHARM BULL, V33, P3369
[7]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF UNCHANGED CIS-DIAMMINEDICHLOROPLATINUM (CISPLATIN) IN PLASMA AND URINE WITH POSTCOLUMN DERIVATIZATION [J].
KINOSHITA, M ;
YOSHIMURA, N ;
OGATA, H ;
TSUJINO, D ;
TAKAHASHI, T ;
TAKAHASHI, S ;
WADA, Y ;
SOMEYA, K ;
OHNO, T ;
MASUHARA, K ;
TANAKA, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (02) :462-467
[8]  
KIZU R, 1985, CHEM PHARM BULL, V33, P4614
[9]  
LEHNINGER AL, 1982, PRINCIPLES BIOCH, P703
[10]   CISPLATINUM - A REVIEW, WITH SPECIAL REFERENCE TO CELLULAR AND MOLECULAR-INTERACTIONS [J].
LITTERST, CL .
AGENTS AND ACTIONS, 1984, 15 (5-6) :520-524